AT371998B - Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels - Google Patents

Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels

Info

Publication number
AT371998B
AT371998B AT0464479A AT464479A AT371998B AT 371998 B AT371998 B AT 371998B AT 0464479 A AT0464479 A AT 0464479A AT 464479 A AT464479 A AT 464479A AT 371998 B AT371998 B AT 371998B
Authority
AT
Austria
Prior art keywords
producing
physiologically acceptable
contrast agent
sterile injectable
ray contrast
Prior art date
Application number
AT0464479A
Other languages
English (en)
Other versions
ATA464479A (de
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Publication of ATA464479A publication Critical patent/ATA464479A/de
Application granted granted Critical
Publication of AT371998B publication Critical patent/AT371998B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/90—In vivo diagnostic or in vivo test agent which contains an additional ingredient to reduce the toxicity or side effects of the active ingredient

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT0464479A 1978-07-04 1979-07-03 Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels AT371998B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7828764 1978-07-04
KR1019790002214A KR830001643B1 (ko) 1978-07-04 1979-07-03 X-선 조영제의 생리적으로 허용되는 멸균 주사용 용액을 제조하는 방법

Publications (2)

Publication Number Publication Date
ATA464479A ATA464479A (de) 1983-01-15
AT371998B true AT371998B (de) 1983-08-25

Family

ID=26268114

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0464479A AT371998B (de) 1978-07-04 1979-07-03 Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels

Country Status (22)

Country Link
US (2) US4278654A (de)
JP (1) JPS5531068A (de)
KR (1) KR830001643B1 (de)
AR (1) AR222337A1 (de)
AT (1) AT371998B (de)
AU (1) AU523295B2 (de)
BE (1) BE877443A (de)
CA (1) CA1132901A (de)
CH (1) CH649469A5 (de)
DE (1) DE2926850C2 (de)
DK (1) DK155714C (de)
ES (1) ES482131A0 (de)
FI (1) FI75492C (de)
FR (1) FR2435253A1 (de)
HK (1) HK59984A (de)
IT (1) IT1193761B (de)
NL (1) NL183121C (de)
NZ (1) NZ190907A (de)
PT (1) PT69869A (de)
SE (1) SE445971B (de)
SG (1) SG5784G (de)
ZA (1) ZA793313B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150916A1 (de) * 1981-12-18 1983-06-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen N-hydroxyaethylierte 2,4,6-trijodaminoisiophthalsaeure-bis- trihydroxybutylamide, deren herstellung und diese enthaltende roentgenkontrastmittel"
US4396598A (en) * 1982-01-11 1983-08-02 Mallinckrodt, Inc. Triiodoisophthalamide X-ray contrast agent
US5035877A (en) * 1985-08-09 1991-07-30 Cook Imaging Corporation Non-ionic contrast media from ionic contrast media
DE3689330T2 (de) * 1985-08-09 1994-05-19 Cook Imaging Corp Nichtionische polyolkontrastmittel aus ionischen kontrastmitteln.
US4718463A (en) * 1985-12-20 1988-01-12 Mallinckrodt, Inc. Method of producing prefilled sterile plastic syringes
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
US4863714A (en) * 1987-02-05 1989-09-05 Cook Imaging Corporation Sterilization of compositions of limited stability
IL94718A (en) * 1989-07-05 1994-10-21 Schering Ag Non-ionic carboxamide contrast agent and method of preparation
US5698739A (en) * 1989-07-05 1997-12-16 Schering Aktiengesellschaft Carboxamide non-ionic contrast media
US5075502A (en) * 1989-12-13 1991-12-24 Mallinckrodt, Inc. Nonionic x-ray contrast agents, compositions and methods
US5191120A (en) * 1989-12-13 1993-03-02 Mallinckrodt Medical, Inc. Process for preparing nonionic X-ray contrast agents
DE4111939A1 (de) * 1991-04-12 1992-10-22 Fresenius Ag Parenteral verabreichbare, hitzesterilisierbare o/w-emulsion eines roentgenkontrastmittels
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
DE4316722A1 (de) * 1993-05-19 1994-11-24 Fresenius Ag Parenteral verabreichbare, unter Hitzesterilisationsbedingungen stabile O/W-Emulsion eines Röntgenkontrastmittels
ES2208884T3 (es) * 1996-01-25 2004-06-16 Schering Aktiengesellschaft Soluciones mejoradas de agentes de contraste para la administracion intravasal.
DE19648650C2 (de) * 1996-01-29 1998-07-02 Schering Ag Puffersysteme und deren Verwendung zur Stabilisierung pharmazeutischer Zubereitung
US6072069A (en) * 1998-11-04 2000-06-06 Biophysica, Inc. Biodegradable nonionic contrast media
US7250153B2 (en) * 2002-12-12 2007-07-31 Biophysica Research, Inc. Contrast media formulations having improved biological tolerance
MX2012010959A (es) * 2010-03-23 2012-11-23 Ge Healthcare As Preparacion de composicion diagnostica de rayos x estabilizada.
US20140377185A9 (en) * 2012-05-30 2014-12-25 Verrow Pharmaceuticals, Inc. Stabilized formulations containing iodinated contrast agents and cyclodextrins

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3190E (fr) * 1904-09-30 Jules Cesar Napoleon Fouilloy Collier d'attache pour protecteur antidérapant de pneumatiques
NL127881C (de) * 1963-03-25
GB1069437A (en) * 1963-10-23 1967-05-17 Nyegaard & Co As Injectable x-ray contrast media
US3733397A (en) * 1966-12-02 1973-05-15 Pharmacia Ab Method for the x-ray visualization of body cavities and a preparation for carrying out the method
SE315975B (de) * 1967-12-28 1969-10-13 Pharmacia Ab
US4021481A (en) * 1969-06-27 1977-05-03 Nyegaard & Co. A/S Amido derivatives of 2,4,6-triiodobenzoic acids containing at least one N-hydroxyalkyl and at least two hydroxyl groups
GB1321591A (en) * 1969-06-27 1973-06-27 Nyegaard & Co As Non-ionic iodinated x-ray contrast agents
CH583562A5 (de) * 1973-07-17 1977-01-14 Bracco Ind Chimica Spa
GB1495679A (en) * 1974-06-17 1977-12-21 Mallinckrodt Inc Substituted isophthalamic acids
US3953497A (en) * 1974-07-29 1976-04-27 Mallinckrodt, Inc. 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof
GB1514920A (en) * 1974-10-09 1978-06-21 Reckitt & Colmann Prod Ltd Dispensing container for medicinal foams
FI760068A7 (de) * 1975-02-03 1976-08-04 Schering Ag
DE2505218A1 (de) * 1975-02-05 1976-08-19 Schering Ag Neue orale roentgenkontrastmittel und verfahren zu ihrer herstellung
GB1548594A (en) * 1976-06-11 1979-07-18 Nyegaard & Co As Triiodoisophthalic acid amides
DE2629228C2 (de) * 1976-06-25 1984-10-18 Schering AG, 1000 Berlin und 4709 Bergkamen Jodierte Isophthalamsäure-Derivate Verfahren zu deren Herstellung sowie deren Verwendung
US4256729A (en) * 1979-03-23 1981-03-17 Mallinckrodt, Inc. N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same

Also Published As

Publication number Publication date
DE2926850C2 (de) 1985-01-24
US4396597A (en) 1983-08-02
DE2926850A1 (de) 1980-03-06
ATA464479A (de) 1983-01-15
PT69869A (en) 1979-08-01
AU523295B2 (en) 1982-07-22
JPS5531068A (en) 1980-03-05
ZA793313B (en) 1980-08-27
FR2435253A1 (fr) 1980-04-04
CH649469A5 (de) 1985-05-31
NL183121C (nl) 1988-08-01
AU4861579A (en) 1980-02-07
BE877443A (fr) 1980-01-03
SE7905830L (sv) 1980-01-05
DK155714C (da) 1989-10-30
ES8200082A1 (es) 1980-12-16
AR222337A1 (es) 1981-05-15
JPS6210209B2 (de) 1987-03-05
FI75492B (fi) 1988-03-31
NL7905166A (nl) 1980-01-08
SG5784G (en) 1985-02-01
FR2435253B1 (de) 1984-03-16
DK280979A (da) 1980-01-05
CA1132901A (en) 1982-10-05
NL183121B (nl) 1988-03-01
ES482131A0 (es) 1980-12-16
KR830001643B1 (ko) 1983-08-22
KR830000911A (ko) 1983-04-28
HK59984A (en) 1984-08-10
FI792101A7 (fi) 1980-01-05
US4278654A (en) 1981-07-14
FI75492C (fi) 1988-07-11
SE445971B (sv) 1986-08-04
DK155714B (da) 1989-05-08
IT1193761B (it) 1988-08-24
NZ190907A (en) 1981-10-19
IT7949618A0 (it) 1979-07-03

Similar Documents

Publication Publication Date Title
AT371998B (de) Verfahren zur herstellung einer sterilen injizierbaren physiologisch annehmbaren loesung eines roentgenkontrastmittels
AT359652B (de) Verfahren zur herstellung eines gewebekleb- stoffes
ATA119079A (de) Verfahren zur herstellung eines gewebekleb- stoffes
AT362082B (de) Verfahren zur herstellung eines desinfektions- mittels
LU79519A1 (de) Verfahren zur herstellung eines wachstumsfoerdernden mittels
AT369990B (de) Verfahren zur herstellung eines gewebeklebstoffes
ATA210680A (de) Verfahren zur herstellung eines wundheilmittels
AT381413B (de) Verfahren zur herstellung einer roentgenroehrendrehanode
AT358166B (de) Verfahren zur herstellung einer verbesserten vakzine gegen newcastle-krankheit
AT382981B (de) Verfahren zur herstellung einer drehanode fuer roentgenroehren
AT371340B (de) Verfahren zur herstellung eines mittels zur behandlung von glaucom
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT363600B (de) Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinylpyrrolidon-komplexes
AT370286B (de) Verfahren zur herstellung eines medizinischdi[tetischen produktes
AT376842B (de) Verfahren zur herstellung einer kathodenstrahlroehre
DD134079A5 (de) Verfahren zur herstellung eines baukoerpers
ATA137581A (de) Verfahren zur herstellung eines pharmazeutischen praeparates
AT367294B (de) Verfahren zur herstellung eines veterinaermedizinischen depotpraeparats
DD131225A1 (de) Verfahren zur herstellung eines festen zahnpflegemittels
DD132404A1 (de) Verfahren zur herstellung eines arzneimitteltraegers
AT365928B (de) Verfahren zur herstellung eines antaziden pharmazeutischen mittels
AT363587B (de) Verfahren zur herstellung eines pharmazeutischen blutstillenden mittels
AT364716B (de) Verfahren zur herstellung eines oral zu verabreichenden pharmazeutischen praeparates zur behandlung der osteoporose
ATA68382A (de) Verfahren zur herstellung eines gewebeklebstoffes
AT378916B (de) Verfahren zur herstellung eines pharmazeutischen kombinationspraeparates

Legal Events

Date Code Title Description
EFA Change in the company name
ELA Expired due to lapse of time